Filing Details

Accession Number:
0001055624-19-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-29 16:15:28
Reporting Period:
2017-11-10
Accepted Time:
2019-03-29 16:15:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055624 A Timothy Springer Harvard Medical School, Ctr
200 Longwood Ave.
Boston MA 02115
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-10 4,752 $9.03 9,752 No 4 P Indirect By wife
Common Stock Acquisiton 2019-01-25 4,000,000 $1.50 4,456,597 No 4 P Direct
Common Stock Acquisiton 2019-01-25 66,666 $1.50 76,418 No 4 P Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By wife
No 4 P Direct
No 4 P Indirect By wife
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.83 to $9.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. Reflects a correction to the Reporting Person's end of period holdings to reflect that 4,752 shares previously shown as held directly are held indirectly by the reporting person's wife.